AE-59-ZQ55_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, Vofopitant, Tachykinin NK1 Antagonists targeting CYP2D6, TACR1 (Novartis, 6918331)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/6918331
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the AE-59-ZQ55_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL37 ribosomal protein L37 1.45674
RPS28 ribosomal protein S28 1.45674
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.977322
PLAC8 placenta-specific 8 0.593362
PPIC peptidylprolyl isomerase C (cyclophilin C) 0.584845
DAD1 defender against cell death 1 0.501546
APRT adenine phosphoribosyltransferase 0.445364
RPL18A ribosomal protein L18a 0.434021
RNF138 ring finger protein 138, E3 ubiquitin protein ligase 0.307717
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase 0.259853
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.243679
EIF5AL1 eukaryotic translation initiation factor 5A-like 1 0.211184

decreased expression

Symbol Name Standardized Value
TFCP2 transcription factor CP2 -0.249383